Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SMX | Smx (Security Matters) Public | $33.96 | $14.68 | 76.14% | 16.6M | $36M | $3.12$34,234.80 |
| RGC | Regencell Bioscience | $52.88 | $19.85 | 60.10% | 3.2M | $26B | $0.09$83.60 |
| NVVE | Nuvve | $3.51 | $1.31 | 59.55% | 81.6M | $4.7M | $1.98$200.80 |
| GLUE | Monte Rosa Therapeutics | $23.28 | $7.27 | 45.41% | 23.2M | $1.5B | $3.50$25.15 |
| ERAS | Erasca | $5.17 | $1.54 | 42.42% | 41.4M | $1.5B | $1.01$6.49 |
| MNTS | Momentus | $13.90 | $4.07 | 41.40% | 25.7M | $19M | $4.73$160.65 |
| ABVE | Above Food Ingredients | $2.46 | $0.67 | 37.43% | 6.6M | $126M | $0.25$6.56 |
| VTYX | Ventyx Biosciences | $13.73 | $3.68 | 36.62% | 28.1M | $980M | $0.78$25.00 |
| TGL | Treasure Global | $8.61 | $2.28 | 36.02% | 4.6M | $13M | $4.51$380.00 |
| ZNTL | Zentalis Pharmaceuticals | $2.42 | $0.64 | 35.95% | 4.7M | $175M | $1.01$3.06 |
Related Articles
Featured Article
Why Shattuck Labs Stock Soared in December
Eric Volkman|Jan 5, 2026
Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug.
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
Up 126% in 3 Days, Is Tango Therapeutics a Buy Right Now?
Alex Carchidi|Aug 17, 2023
Remember that past performance doesn't predict future returns.
Advertisement
My Take: 4 Cheap Growth Stocks to Buy This Week
Jose Najarro|Jun 21, 2021
These four stocks are providing solutions in innovative markets.
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This 2020 Biotech IPO Is Poised to Break Out in 2021
Patrick Bafuma|Apr 2, 2021
Revolution Medicines' leading compound is shaping up to be a platform in a pill.
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Is It Too Late to Jump In on Zentalis?
James Halley|Jun 3, 2020
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
David Haen|Apr 23, 2020
These companies just raised significant cash to advance promising drug pipelines.
